A randomized, placebo-controlled trial of the quadrivalent human papillomavirus vaccine in human immunodeficiency virus-infected adults aged 27 years or older …

TJ Wilkin, H Chen, MS Cespedes… - Clinical Infectious …, 2018 - academic.oup.com
Background Adults living with human immunodeficiency virus (HIV) are at increased risk for
anal and oropharyngeal cancer caused by human papillomavirus (HPV). The efficacy of …

Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men

T Wilkin, JY Lee, SY Lensing, EA Stier… - The Journal of …, 2010 - academic.oup.com
Background. Human immunodeficiency virus type 1 (HIV-1)-infected men are at increased
risk for anal cancer. Human papillomavirus (HPV) vaccination may prevent anal cancer …

High prevalence of anal high-grade squamous intraepithelial lesions, and prevention through human papillomavirus vaccination, in young men who have sex with …

JM Palefsky, SY Lensing, M Belzer, J Lee… - Clinical Infectious …, 2021 - academic.oup.com
Background Men who have sex with men (MSM) are at high risk for human papillomavirus
(HPV)–related anal cancer. Little is known about the prevalence of low-grade squamous …

Long-term outcomes of adding HPV vaccine to the anal intraepithelial neoplasia treatment regimen in HIV-positive men who have sex with men

AA Deshmukh, J Chhatwal, EY Chiao… - Clinical Infectious …, 2015 - academic.oup.com
Background. Recent evidence shows that quadrivalent human papillomavirus (qHPV)
vaccination in men who have sex with men (MSM) who have a history of high-grade anal …

Clinical effectiveness and cost-effectiveness of quadrivalent human papillomavirus vaccination in HIV-negative men who have sex with men to prevent recurrent high …

AA Deshmukh, EY Chiao, P Das, SB Cantor - Vaccine, 2014 - Elsevier
We examined the long-term clinical and economic benefits of quadrivalent human
papillomavirus (qHPV) vaccine as a secondary/adjunct prevention strategy in the prevention …

Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study

KA Swedish, SH Factor… - Clinical infectious …, 2012 - academic.oup.com
Background. Most squamous cell anal cancers and precancerous lesions are attributed to
human papillomavirus (HPV) infection. By preventing HPV infection, quadrivalent HPV …

Human papillomavirus vaccine efficacy and effectiveness against cancer

S Kamolratanakul, P Pitisuttithum - Vaccines, 2021 - mdpi.com
Human papillomavirus (HPV) is the most common sexually transmitted infection, with 15
HPV types related to cervical, anal, oropharyngeal, penile, vulvar, and vaginal cancers …

Quadrivalent human papillomavirus (HPV) vaccine induces HPV-specific antibodies in the oral cavity: results from the mid-adult male vaccine trial

LA Pinto, TJ Kemp, BN Torres… - The Journal of …, 2016 - academic.oup.com
Background. Human papillomavirus virus type 16 (HPV-16) and HPV-18 cause a large
proportion of oropharyngeal cancers, which are increasing in incidence among males, and …

HPV vaccine against anal HPV infection and anal intraepithelial neoplasia

JM Palefsky, AR Giuliano, S Goldstone… - … England Journal of …, 2011 - Mass Medical Soc
Background The rate of anal cancer is increasing among both women and men, particularly
men who have sex with men. Caused by infection with human papillomavirus (HPV) …

Vaccine effectiveness against prevalent anal and oral human papillomavirus infection among men who have sex with men—United States, 2016–2018

E Meites, RL Winer, ME Newcomb… - The Journal of …, 2020 - academic.oup.com
Abstract Background In the United States, human papillomavirus (HPV) vaccination has
been recommended for young adult men who have sex with men (MSM) since 2011 …